Long-term follow-up of an RCT in 250 patients with Bowen's disease: 4-year estimated tumour-free survival was 97.5% with excision, 86.2% with 5-fluorouracil and 82.7% with MAL-PDT; 5FU stayed non-inferior, MAL-PDT did not show non-inferiority.
RCTn = 250
Moermans et al. Surgical excision versus topical 5% 5-fluorouracil and photodynamic therapy in the treatment of Bowen's disease: Long-term results of a multicenter randomized controlled trial